InvestorsObserver is giving Prelude Therapeutics Inc (PRLD) an Analyst Rating Rank of 23, meaning PRLD is ranked higher by analysts than 23% of stocks. The average price target for PRLD is $6.6 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating PRLD a Buy today. Find out what this means to you and get the rest of the rankings on PRLD!
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Prelude Therapeutics Inc Stock Today?
Prelude Therapeutics Inc (PRLD) stock is trading at $2.00 as of 1:14 PM on Thursday, Nov 2, an increase of $0.14, or 7.53% from the previous closing price of $1.86. The stock has traded between $1.74 and $2.13 so far today. Volume today is above average. So far 129,946 shares have traded compared to average volume of 94,043 shares.
Click Here to get the full Stock Report for Prelude Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
